Back to Selection     Print       Date : 30 Apr 2026
Fund Summary
Templeton India Value Fund (G)
[Equity: Value]  
 
Fund Details
Fund Type Growth Launch Date 02-Sep-96
Corpus(Cr.) 2150.0 Latest NAV 689.4916 As on 12-06-2026
Equity(%) 93.58 52 Week High 749.696
Debt(%) 3.87 52 Week Low 646.361
Others(%) 2.55 Exit Load 1% for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.18
Scheme Benchmark NIFTY 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Ajay Argal
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide long-term capital appreciation to its Unitholders by following a value investment strategy.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 28.89%
Top 10 Holdings 47.05%
Top 25 Holdings 77.60%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 28.15
Software & Services 9.68
Retail 7.63
Petroleum Products 7.37
Pharma & Biotech 6.43
Finance & Investments 5.64
Oil & GAS 5.47
Energy 5.43
Cash 3.87
Automobile 3.22
Industrial Products 3.02
Construction 2.51
Ferrous Metals 2.46
FMCG 2.34
SERVICES 1.67
Telecom 1.33
Agricultural & Farm Machinery 1.21
Electricals 0.77
Consumer Durables 0.69
Communication 0.6
Transportation 0.51
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.18
PE Ratio 16.33
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 7.27
Axis Bank Limited 6.49
Reliance Industries Limited 6.32
ICICI Bank Limited 4.55
Tata Consultancy Services Limited 4.26
OIL & NATURAL GAS CO. 4.18
Net Asset 3.87
State Bank of India 3.48
Infosys Limited 3.41
Maruti Suzuki India Limited 3.22
Cipla Limited 3.05
Brookfield India Real Estate Trust 2.55
Tata Steel Limited 2.46
ITC Limited 2.34
REC Limited 2.25
NTPC Limited 2.04
RATNAKAR BANK LIMITED 2.03
Kirloskar Oil Eng Ltd 1.97
Dr Reddys Laboratories Limited 1.85
Bandhan Bank Limited 1.76
POWER GRID CORPORATION OF INDI 1.70
CESC Limited 1.69
HDB Financial Services Limited 1.68
Emami Limited 1.65
Akums Drugs & Pharmaceuticals Ltd. 1.53

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
0.26% 2.20% -6.62% -2.57%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
0.09% 2.31% -8.96% -3.41%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
0.43% 5.87% -4.42% -0.43%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
-1.64% 12.50% 14.19% 14.04%
 
 
1.41% 9.21% 9.61% 12.64%
 
 
1.78% 13.06% 11.87% 14.01%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Templeton India Value Fund (G) 14.74% 0.4459 11.6064% 42.0624 0.0822
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Templeton India Value Fund (G) 3.9195% 0.0004 0.0759 6.2436 0.7896
 
Back to Selection